Previous 10 | Next 10 |
Channelchek news releases related Channelchek news releases and Channelchek press releases from 11/16/21 12:00:00 on US and Canada Markets.
3Q21 Results. Revenue totaled $31.8 million, up from $30.7 million sequentially, and up 328.4% over the same period last year. Adjusted EBITDA for the quarter was $8.8 million, down from $10.0 million sequentially and representing a 27.6% margin. Schwazze recorded net income of $968,756, or $0...
Preparation for upcoming drilling. Allegiant Gold has started road construction in and around the recently discovered high-grade zone within the western edge of the original pit zone at its Eastside gold deposit near Tonopah, Nevada. Roads will also be built in and around areas to the east and...
3Q21 Reported. Cocrystal reported a 3Q21 loss of $3.9 million or $(0.04) per share, compared with our expected loss of $3.1 million or $(0.03) per share. The company also confirmed the projected early 2022 start for its Phase 1 Influenza trial, and updated progress on the intranasal and orally...
Off to a good start. Fiscal first quarter revenues were on point at $16.4 million, with lower than expected Adj. EBITDA loss of $2.6 million, versus our $4.3 million loss estimate. The results were influenced by a large number of acquisitions, including the recent acquisition of BetHard. In ad...
Voyager Digital Ltd. ("Voyager" or the "Company") (TSX: VOYG; OTCQX: VYGVF; FRA: UCD2) one of the fastest-growing, publicly traded cryptocurrency platforms in the United States, today announced revenue and user metrics for the Fiscal 2022 First Quarter ended September 30, 2021. Read More >...
Adjusted EBITDA loss of $1.3 million below expectations. Lower TCE revenue of $3.4 million and $7.0k/day and higher opex of $6.8k/day drove the negative variance. Adjusted 3Q2021 EBITDA losses of $1.3 million were below our estimate due to lower TCE revenue and higher opex and G&A expenses...
Disguise. While we do not want to get ahead of ourselves given the ongoing impact of COVID worldwide, in the non-COVID 2019, disguise generated about $14 million of revenue for live event products. We would expect the majority of this revenue to return over time and will be additive to the cur...
3Q22 reported. Onconova Therapeutics reported 3Q21 loss of $3.5 million or $(0.22) per share, compared with our estimated loss of $5.2 million or $(0.33) per share. On its quarterly conference call, the company reviewed clinical progress during the quarter and discussed plans for trials in 202...
Disguise. While we do not want to get ahead of ourselves given the ongoing impact of COVID worldwide, in the non-COVID 2019, disguise generated about $14 million of revenue for live event products. We would expect the majority of this revenue to return over time and will be additive to the cur...
The skyrocketing use of batteries and growing plans to include lithium-ion (Li-ion) batteries as a solution to many of today’s environmental initiatives has challenges. Not the least of these is that the mining of lithium has a number of negative impacts on the environment. One of which...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
17.93%Change Percent:
OneWater Marine Inc. Company Name:
ONEW Stock Symbol:
NASDAQ Market:
onewatermarine.com Website: